Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial
Oxerutin therapy might reduce RVO by promoting DVT resolution. These preliminary findings support further investigation in a large-scale trial to assess the long-term prevention of PTS.
Authors
- Daan J.L. van Twist (ORCID: https://orcid.org/0000-0001-8433-8030)
- Hugo Ten Cate (ORCID: https://orcid.org/0000-0001-7796-4463)
- Rutger Brans (ORCID: https://orcid.org/0000-0002-7423-5182)
- Arina J. ten Cate‐Hoek (ORCID: https://orcid.org/0000-0002-9900-6212)
- Ruben D Hupperetz (ORCID: https://orcid.org/0009-0003-2776-9143)
- Aaron F.J. Iding (ORCID: https://orcid.org/0000-0003-2880-6850)
Institutions
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- Zuyderland Medisch Centrum (NL)
Publication Details
- Journal
- Journal of Thrombosis and Haemostasis
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.jtha.2025.10.018
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00